Sanofi, Regeneron say latest Dupixent eczema drug tests positive

PARIS (Reuters) - Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dupixent product aimed at adults with eczema or moderate-to-severe atopic dermatitis (AD) had been positive.